Adipocyte-specific protein homologs
AssigneeZymoGenetics, Inc.
InventorsPaul O. Sheppard, Jacqueline M. Humes
Life of this patent
Estimating the term…
Abstract
The present invention relates to polynucleotide and polypeptide molecules for zsig39, a novel member of the family of proteins bearing a collagen-like domain and a globular domain. The polypeptides, and polynucleotides encoding them, are involved in dimerization or oligomerization and may be used in the study thereof. The present invention also includes antibodies to the zsig39 polypeptides.
Claims37
An isolated polypeptide comprising a sequence of amino acid residues that is at least 80% identical to SEQ ID NO:2, wherein said sequence comprises:
- beta strands corresponding to amino acid residues 105-109, 128-130, 136-139, 143-146, 164-171, 176-182, 187-200, 204-210 and 226-231 of SEQ ID NO:2, wherein the beta strands are separated by at least two amino acid residues;
- and
- a receptor binding domain comprising amino acid residues 111-135 and 170-174 of SEQ ID NO:2.
An isolated polypeptide according to claim 2, wherein said polypeptide is at least 90% identical to SEQ ID NO:2.
An isolated polypeptide selected from the group consisting of:
- a) a polypeptide having a sequence of amino acid residues from amino acid residue 30 to amino acid residue 95 of SEQ ID NO:2;
- b) a polypeptide having a sequence of amino acid residues from amino acid residue 30 to amino acid residue 96 of SEQ ID NO:2;
- and
- c) a polypeptide having a sequence of amino acid residues from amino acid residue 30 to 97 of SEQ ID NO:2;
- d) a polypeptide having a sequence of amino acid residues from amino acid residue 30 to amino acid residue 98 of SEQ ID NO:2;
- e) a polypeptide having a sequence of amino acid residues from amino acid residue 98 to amino acid residue 243 of SEQ ID NO:2;
- f) a polypeptide having a sequence of amino acid residues from amino acid residue 99 to amino acid residue 243 of SEQ ID NO:2;
- g) a polypeptide having a sequence of amino acid residues from amino acid residue 30 to amino acid residue 243 of SEQ ID NO:2;
- and
- h) a polypeptide having a sequence of amino acid residues that is 90% identical in amino acid sequence to a), b), c), d), e), f), g) or h).
A fusion protein consisting essentially of a first portion and a second portion joined by a peptide bond, said first portion comprising a polypeptide selected from the group consisting of:
- a) a polypeptide comprising a sequence of amino acid residues that is at least 80% identical to SEQ ID NO:2, wherein said sequence comprises:
- beta strands corresponding to amino acid residues 105-109, 128-130, 136-139, 143-146, 164-171, 176-182, 187-200, 204-210 and 226-231 of SEQ ID NO:2, wherein the beta strands are separated by at least two amino acid residues;
- and a receptor binding domain comprising amino acid residues 111-135 and 170-174 of SEQ ID NO:2;
- b) a polypeptide comprising a sequence of amino acid residues as shown in SEQ ID NO:2 from amino acid residue 16 to amino acid residue 243;
- c) a polypeptide comprising a sequence of amino acid residues as shown in SEQ ID NO:2 from amino acid residue 1 to amino acid residue 243;
- d) a portion of the zsig39 polypeptide as shown in SEQ ID NO:2 containing the collagen-like domain or a portion of the collagen-like domain capable of dimerization or oligomerization;
- e) a portion of the zsig39 polypeptide as shown in SEQ ID NO:2, containing the globular-like domain or the receptor binding portion of the globular-like domain;
- or
- f) a portion of the zsig39 polypeptide as shown in SEQ ID NO:2, including the collagen-like domain and the globular domain;
- and
- said second portion comprising another polypeptide.
A fusion protein comprising a secretory signal sequence having the amino acid sequence of amino acid residues 1-15 or 1-18 of SEQ ID NO:2, wherein said secretory signal sequence is operably linked to an additional polypeptide.
An isolated polynucleotide encoding a polypeptide comprising a sequence of amino acid residues that is at least 80% identical to SEQ ID NO:2, wherein said sequence comprises:
- beta strands corresponding to amino acid residues 105-109, 128-130, 136-139, 143-146, 164-171, 176-182, 187-200, 204-210 and 226-231 of SEQ ID NO:2, wherein the beta strands are separated by at least two amino acid residues;
- and
- a receptor binding domain comprising amino acid residues 111-135 and 170-174 of SEQ ID NO:2.
An isolated polynucleotide selected from the group consisting of:
- a) a sequence of nucleotides from nucleotide 243 to nucleotide 962 of SEQ ID NO:1;
- b) a sequence of nucleotides from nucleotide 252 to nucleotide 962 of SEQ ID NO:1;
- c) a sequence of nucleotides from nucleotide 285 to nucleotide 482 of SEQ ID NO:1;
- d) a sequence of nucleotides from nucleotide 285 to nucleotide 485 of SEQ ID NO:1;
- e) a sequence of nucleotides from nucleotide 285 to nucleotide 488 of SEQ ID NO:1;
- f) a sequence of nucleotides from nucleotide 285 to nucleotide 491 of SEQ ID NO:1;
- g) a sequence of nucleotides from nucleotide 285 to nucleotide 926 of SEQ ID NO:1;
- h) a sequence of nucleotides from nucleotide 491 to nucleotide 926 of SEQ ID NO:1;
- i) a polynucleotide encoding a polypeptide having a sequence of nucleotides that is at least 80% identical in nucleotide sequence to a), b), c), d), e), f), g) and h);
- j) nucleotide sequences complementary to a), b), c), d), e), f), g), h) or i);
- and
- k) degenerate nucleotide sequences of a), b), c) d), e), f), g), h), i) or j).
An isolated polynucleotide encoding a fusion protein consisting essentially of a first portion and a second portion joined by a peptide bond, said first portion is selected from the group consisting of:
- a) a polypeptide comprising a sequence of amino acid residues that is at least 80% identical to SEQ ID NO:2, wherein said sequence comprises:
- beta strands corresponding to amino acid residues 105-109, 128-130, 136-139, 143-146, 164-171, 176-182, 187-200, 204-210 and 226-231 of SEQ ID NO:2, wherein the beta strands are separated by at least two amino acid residues;
- and a receptor binding domain comprising amino acid residues 111-135 and 170-174 of SEQ ID NO:2;
- b) a polypeptide comprising a sequence of amino acid residues as shown in SEQ ID NO:2 from amino acid residue 16 to amino acid residue 243;
- c) a polypeptide comprising a sequence of amino acid residues as shown in SEQ ID NO:2 from amino acid residue 1 to amino acid residue 243;
- d) a portion of the zsig39 polypeptide as shown in SEQ ID NO:2 containing the collagen-like domain or a portion of the collagen-like domain capable of dimerization or oligomerization;
- e) a portion of the zsig39 polypeptide as shown in SEQ ID NO:2, containing the globular-like domain or an active portion of the globular-like domain;
- or
- f) a portion of the zsig39 polypeptide as shown in SEQ ID NO:2, including the collagen-like domain and the globular domain;
- and
- said second portion comprising another polypeptide.
An isolated polynucleotide encoding a fusion protein comprising a secretory signal sequence having the amino acid sequence of amino acid residues 1-15 or 1-18 of SEQ ID NO:2, wherein said secretory signal sequence is operably linked to an additional polypeptide.
An isolated polynucleotide comprising the sequence of nucleotide 1 to nucleotide 729 of SEQ ID NO:10.
An oligonucleotide probe or primer comprising at least 14 contiguous nucleotides of a polynucleotide of SEQ ID NO:10 or a sequence complementary to SEQ ID NO:10.
An isolated polynucleotide encoding a polypeptide selected from the group consisting of:
- a) a polypeptide comprising a sequence of amino acid residues from amino acid residue 30 to amino acid residue 95 of SEQ ID NO:2;
- b) a polypeptide comprising a sequence of amino acid residues from amino acid residue 30 to amino acid residue 96 of SEQ ID NO:2;
- c) a polypeptide comprising a sequence of amino acid residues from amino acid residue 30 to amino acid residue 97 of SEQ ID NO:2;
- d) a polypeptide comprising a sequence of amino acid residues from amino acid residue 98 to amino acid residue 243 of SEQ ID NO:2;
- e) a polypeptide comprising a sequence of amino acid residues from amino acid residue 99 to amino acid residue 243 of SEQ ID NO:2;
- and
- f) a polypeptide comprising a sequence of amino acid residues from amino acid residue 30 to amino acid residue 243 of SEQ ID NO:2.
Dependencies are inferred from the claim text.